These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 28859117

  • 1. Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer.
    Jia ZH, Jia Y, Guo FJ, Chen J, Zhang XW, Cui MH.
    PLoS One; 2017; 12(8):e0183622. PubMed ID: 28859117
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S, Sun J, Cai B, Xi X, Yang L, Zhang Z, Feng Y, Sun Y.
    Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
    [Abstract] [Full Text] [Related]

  • 5. IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway.
    Guo QY, Song JN, Chen YM, Yuan HN, Xue WS, Sun Y, Niu XL, Wang Y, Chen X.
    Med Oncol; 2024 May 14; 41(6):155. PubMed ID: 38744773
    [Abstract] [Full Text] [Related]

  • 6. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
    Zou M, Zhang X, Xu C.
    Cell Oncol (Dordr); 2016 Feb 14; 39(1):47-57. PubMed ID: 26510945
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of the interleukin 6 receptor family in epithelial ovarian cancer and its clinical implications.
    Kumar J, Ward AC.
    Biochim Biophys Acta; 2014 Apr 14; 1845(2):117-25. PubMed ID: 24388871
    [Abstract] [Full Text] [Related]

  • 15. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
    Dai C, Xie Y, Zhuang X, Yuan Z.
    Biomed Pharmacother; 2018 Aug 14; 104():763-770. PubMed ID: 29807226
    [Abstract] [Full Text] [Related]

  • 16. PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling.
    Jia Y, Shi H, Cao Y, Feng W, Li M, Li X.
    Life Sci; 2019 Sep 15; 233():116715. PubMed ID: 31376371
    [Abstract] [Full Text] [Related]

  • 17. Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.
    Saini U, Naidu S, ElNaggar AC, Bid HK, Wallbillich JJ, Bixel K, Bolyard C, Suarez AA, Kaur B, Kuppusamy P, Hays J, Goodfellow PJ, Cohn DE, Selvendiran K.
    Oncogene; 2017 Jan 12; 36(2):168-181. PubMed ID: 27292260
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.